JDRF Blog

Latest in Clinical trials

  • Advancing the Cure with Type 1 Diabetes Clinical Trials

    May 20, 2019

     JDRF funds type 1 diabetes (T1D) clinical trials that are critical to bringing new devices and treatments to people with this disease....

  • In First-In-Human Tests, New Artificial Pancreas System Smartphone App Shows Reliable Glucose Control

    February 25, 2019

    Artificial pancreas (AP) systems “close the loop” between continuous glucose monitors and insulin pumps, using a computer algorithm to calculate and administer...

  • JDRF Drives Next-Generation Type 1 Diabetes Research With New Partnerships & Breakthrough Science

    December 22, 2018

    JDRF, the leading global organization funding type 1 diabetes (T1D) research, announced today that it made progressive advances this year on its...

  • JDRF’s Leadership Role: Top-Line Research at ADA’s Scientific Sessions

    June 29, 2018

    People with type 1 diabetes (T1D) have to live with it 24 hours a day, 7 days a week, 365 days a...

  • JDRF Heads to ADA’s 78th Scientific Sessions

    June 20, 2018

    Where do top scientific minds share the latest advances in diabetes research? The American Diabetes Association’s (ADA’s) 78th Scientific Sessions convenes from...

  • Zynquista™ (sotagliflozin) New Drug Application Accepted by the FDA

    May 23, 2018

    Lexicon Pharmaceuticals Inc., in partnership with Sanofi, announced recently that the U.S. Food and Drug Administration (FDA) has accepted Sanofi’s New Drug...

  • T1D Clinical Trials

    May 21, 2018

    JDRF funds type 1 diabetes (T1D) clinical trials that are critical to bringing new devices and treatments to people with T1D. Currently,...

  • Intranasal Insulin to Treat Low Blood Sugar Unawareness

    May 3, 2018

    Type 1 diabetes (T1D) can bring the fear of developing low blood sugar, called hypoglycemia, which can arise if someone takes too...

  • T1D Research on the Horizon

    January 16, 2018

    What we’re looking forward to in 2018 It may be risky to speculate on the next research breakthrough. But at JDRF we...